Angus Duncan

Angus Duncan

Associate
Baker & McKenzie LLP
Not admitted to practice law in this jurisdiction

Biography

Angus is an associate in Baker McKenzie’s Corporate Group currently based in Los Angeles. His practice focuses on all general corporate matters, including cross-border mergers and acquisitions, global reorganisations, carve-outs and acquisitions and divestments by private equity and private clients. A large proportion of his work is also in relation to cross-border or multinational transactions.

Representative Legal Matters

  • Advised New Mountain Capital, LLC on its USD 2.3 billion spinoff acquisition of the Applied, Food and Enterprise Services businesses from the Discovery & Analytical Solutions segment of PerkinElmer, Inc.
  • Advised Core Equity and Portman Dental on the acquisition of Dentex.
  • Advised Xperi Holding Corporation on aspects of its USD 120 million acquisition of Vewd Software Holding Limited.
  • Advised Kantar on the carve-out sale of its global public consulting business.
  • Advised Equinix, Inc. on a number of joint ventures with GIC and PGIM in relation to the development and operation of hyperscale data centres (total value of USD 6 billion).
  • Advised Hitachi Ltd. on its USD 11 billion acquisition of ABB’s power grids business in over 100 jurisdictions (the largest-ever acquisition by a Japanese industrial company).
  • Advised GSK on the proposed sale of its USD 500 million Cephalosporin antibiotics business to Sandoz, a Novartis division.
  • Advised KKR on its acquisition and Wella joint venture with Coty for the professional beauty and retail hair business for USD 4.3 billion, a highly complex carve-out across more than 70 countries.

Admissions

  • England & Wales (2022)

Education

  • BPP University Law School (Master of Laws in Commercial Legal Practice) (2020)
  • Oxford University (BA Jurisprudence) (2018)

Previous Offices

  • London